Skip to main content
Log in

Hyponatremia reflects mortality risks other than myocardial damage in acute coronary syndrome

  • CE-Research Letter to the Editor
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Goldberg A, Hammerman H, Petcherski S et al (2006) (2006) Hyponatremia and long-term mortality in survivors of acute ST-elevation myocardial infarction. Arch Intern Med 166(7):781–786

    Article  Google Scholar 

  2. Burkhardt K, Kirchberger I, Heier M et al (2015) Hyponatraemia on admission to hospital is associated with increased long-term risk of mortality in survivors of myocardial infarction. Eur J Prev Cardiol 22(11):1419–1426

    Article  Google Scholar 

  3. Klein L, O’Connor CM, Leimberger JD et al (2005) Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study. Circulation 111(19):2454–2460

    Article  CAS  Google Scholar 

  4. LeJemtel TH, Serrano C (2007) Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure. Int J Cardiol 120(1):1–9

    Article  Google Scholar 

  5. Chia S, Senatore F, Raffel OC, Lee H, Wackers FJ, Jang IK (2008) Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 1(4):415–423

    Article  Google Scholar 

  6. Pride YB, Giuseffi JL, Mohanavelu S et al (2010) Relation between infarct size in ST-segment elevation myocardial infarction treated successfully by percutaneous coronary intervention and left ventricular ejection fraction three months after the infarct. Am J Cardiol 106(5):635–640

    Article  Google Scholar 

  7. Matsuo S, Imai E, Horio M et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992

    Article  CAS  Google Scholar 

  8. Bhatt DL, Topol EJ (2005) Does creatinine kinase-MB elevation after percutaneous coronary intervention predict outcomes in 2005? Periprocedural cardiac enzyme elevation predicts adverse outcomes. Circulation 112(6):906–915

    Article  CAS  Google Scholar 

  9. Gollop ND, Dhullipala A, Nagrath N, Myint PK (2013) Is periprocedural CK-MB a better indicator of prognosis after emergency and elective percutaneous coronary intervention compared with post-procedural cardiac troponins? Interact Cardiovasc Thorac Surg 17(5):867–871

    Article  Google Scholar 

  10. Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR (2003) Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention. Int J Cardiol 92(2–3):285–293

    Article  Google Scholar 

  11. Sotirakopoulos N, Kalogiannidou I, Tersi M, Armentzioiou K, Sivridis D, Mavromatidis K (2012) Acid-base and electrolyte disorders in patients with diabetes mellitus. Saudi J Kidney Dis Transpl 23(1):58–62

    PubMed  Google Scholar 

  12. Shapiro DS, Sonnenblick M, Galperin I, Melkonyan L, Munter G (2010) Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome. Intern Med J 40(8):574–580

    Article  CAS  Google Scholar 

  13. Arques S, Ambrosi P (2011) Human serum albumin in the clinical syndrome of heart failure. J Card Fail 17(6):451–458

    Article  CAS  Google Scholar 

  14. Kim DR, Cho JH, Jang WS et al (2013) Severe hyponatremia associated with the use of angiotensin II receptor blocker/thiazide combinations. Electrolyte Blood Press 11(2):56–59

    Article  Google Scholar 

  15. Milionis HJ, Liamis GL, Elisaf MS (2002) The hyponatremic patient: a systematic approach to laboratory diagnosis. CMAJ 166(8):1056–1062

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masayuki Tanemoto.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical approval

The study was approved by the ethics committee of Shin-Kuki General Hospital (Approved number 0001) and written informed consent from individual patients was waived.

Statement of human and animal rights

All procedures performed in the studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Any studies with animals were not conducted.

Informed consent

The study was approved by the hospital ethics committee and written informed consent from individual patients was waived.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tanemoto, M., Suenaga, S. Hyponatremia reflects mortality risks other than myocardial damage in acute coronary syndrome. Intern Emerg Med 17, 1235–1237 (2022). https://doi.org/10.1007/s11739-021-02915-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11739-021-02915-5

Navigation